All patients | Female postmenopausal | Female premenopausal | male | |||||
---|---|---|---|---|---|---|---|---|
Spearman’s rho | p-value | Spearman’s rho | p-value | Spearman’s rho | p-value | Spearman’s rho | p-value | |
AVP CSF vs. Na | − 0.237 [− 0.554 to 0.140] | 0.208 | − 0.694* [− 0.913 to − 0.164] | 0.008 | − 0.8 [− 0.998 to 0.819] | 0.333 | 0.283 [− 0.329 to 0.727] | 0.349 |
AVP plasma vs. Na | 0.002 [− 0.359 to 0.362] | 0.993 | − 0.23 [− 0.697 to 0.375] | 0.45 | − 0.2 [− 0.975 to 0.944] | 0.917 | 0.2 [− 0.400 to 0.680] | 0.513 |
AVP saliva vs. Na | − 0.135 [− 0.474 to 0.238] | 0.476 | − 0.066 [− 0.596 to 0.504] | 0.829 | 0 [− 0.961 to 0.961] | 1 | − 0.153 [− 0.651 to 0.438] | 0.619 |
AVP CSF vs. Hkt | 0.051 [− 0.316 to 0.404] | 0.791 | − 0.522 [− 0.845 to 0.081] | 0.071 | 0.4 [− 0.924 to 0.986] | 0.75 | 0.286 [− 0.326 to 0.729] | 0.344 |
AVP plasma vs. Hkt | − 0.063 [− 0.415 to 0.304] | 0.739 | − 0.22 [− 0.691 to 0.383] | 0.47 | 0.4 [− 0.924 to 0.986] | 0.75 | − 0.313 [− 0.744 to 0.301] | 0.297 |
AVP saliva vs. Hkt | 0.063 [− 0.304 to 0.414] | 0.74 | 0.132 [− 0.454 to 0.638] | 0.669 | 0.4 [− 0.924 to 0.986] | 0.75 | 0.198 [− 0.401 to 0.678] | 0.517 |